Novartis receives approval from FDA to market Prevacid(R) 24HR as first and only OTC proton pump inhibitor in original prescript

2009-05-20 アップロード · 76 視聴

Novartis announced today that Prevacid® 24HR (lansoprazole delayed-release capsules 15 mg) has been approved by the U.S. Food and Drug Administration (FDA) as the first over-the-counter (OTC) Proton Pump Inhibitor (PPI) for the treatment of frequent heartburn since 2003. Prevacid 24HR is expected to be available over-the-counter in 2009.

To view Multimedia News Release, go to http://www.prnewswire.com/mnr/prevacid/38457/

tag·Novartis,Prevacid,24HR,frequent,heartburn,Multivu,38457

非会員の場合は、名前/パスワードを入力してください。

書き込む
今日のアクセス
18
全体アクセス
131,539
チャンネル会員数
35

My Video

リスト形式で表示 碁盤形式で表示